Pharma companies seek hike in drug rates under price control
Chinese API imports turn 200% costlier, making production costlier in India. Over 70% of the country’s total bulk drug requirement comes from China. These bulk drugs or active pharmaceutical ingredients (API) are used in producing medicines, including essential items like antibiotics, vitamins and folic acid.
Smallcap Hunters: API plans make Shivalik Rasayan valuations look very compelling
The company’s core business of pesticides has steadily been...
Ansal API Group to give assets details
Suneal Mangal has also filed separate criminal proceedings alleging intimidation by Ansal API managing...
Aurobindo Pharma gets 8 observations for 2 plants from USFDA
The company will be responding to the USFDA as per the prescribed time lines, the drug firm said.
PFRDA to reach 45 crore people in unorganised sector: Member
PERDA the authority which runs, APY and NPS has around 3 crore subscribers is now looking to cover 45 crore people in the unorganised sector with no access to any financial products. Around 55% of the total subscribers are under the APY scheme.
Air Quality in Delhi reaches ‘poor’ category
With a dip in mercury in the national capital, air quality recorded in ‘Poor’ category on October 15. According to Air Quality Index (AQI), ...
Microsoft India, IIT Delhi to bring technical solutions for the differently-abled
In the four-day conference, sessions, including workshops and seminars to understand disabilities and assistive technologies will be discussed.
Allow consumers to select, modify channels on TRAI app: regulator to cable, DTH firms
The Telecom Regulatory Authority of India (Trai) has asked cable and satellite TV providers to allow consumers to access and modify their subscription plans via Trai app.
KSUM, EDB join hands to promote innovation in fintech
The agreement aims at building business opportunities for each country’s startups in other’s market.
Glenmark in talks to sell up to 30% in API biz to PremjiInvest
The pharma group plans to sell minority stake for $150m in their new subsidiary of active pharmaceutical ingredient products. Discussions are ongoing with True North
Mylan to invest $1 billion in India on capex in 6 years
Currently Mylan has 21 facilities and 15,000 employees working in India.
USFDA issues 6 observations to Natco Pharma's API facility near Hyderabad
The United States Food and Drug Administration (USFDA) conducted inspection at Kothur facility between August 5-9, 2019.
Supply risks remain, Brent price likely to rise back to $68-69 zone
A bearish inventory report from the US EIA did little to bring crude oil prices down.
HDFC Bank to offer pre-approved car loans
Lender working on interfaces with car makers which allows it to offer instant pre-approved loans to vehicle buyers.
Central drug regulator preparing list of dual-use APIs imported from unregistered firms
Dual-use APIs, which are being imported from unregistered companies, are comparatively cheaper and of low-quality.
Copyright © 2019 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service